Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Active, not recruiting
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +85 more
Nov 25, 2022

COVID-19 Trial in United States (other, drug, biological)

Completed
Has Results
  • COVID-19
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +31 more
Nov 23, 2022

COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)

Terminated
Has Results
  • COVID-19
  • Convalescent Plasma
  • Masked Saline Placebo
  • Birmingham, Alabama
  • +23 more
Sep 9, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)

Completed
  • COVID-19
  • Lenzilumab
  • +2 more
  • Birmingham, Alabama
  • +55 more
Jul 21, 2022

COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +38 more
Jul 21, 2022

COVID-19 Outcome Prediction Algorithm

Active, not recruiting
  • COVID-19
  • +4 more
  • Blood and nasal swab sampling
  • Los Angeles, California
  • +6 more
Jul 20, 2022

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
Has Results
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

COVID-19 Trial in Worldwide (Dapagliflozin 10 milligram (mg), Placebo)

Completed
Has Results
  • COVID-19
  • Dapagliflozin 10 milligram (mg)
  • Placebo
  • Fairhope, Alabama
  • +94 more
May 13, 2022

COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +62 more
Jun 1, 2022

COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)

Active, not recruiting
Has Results
  • COVID-19
  • +2 more
  • Convalescent Plasma
  • Saline solution
  • New Haven, Connecticut
  • +8 more
Mar 30, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +59 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
Has Results
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)

Terminated
Has Results
  • COVID-19
  • Apixaban 2.5 MG
  • +3 more
  • Los Angeles, California
  • +70 more
Feb 15, 2022

COVID-19 Trial in Fort Lauderdale, Bronx (Nitazoxanide, Placebo, Vitamin Super B-Complex)

Completed
  • COVID-19
  • Fort Lauderdale, Florida
  • +1 more
Feb 10, 2022